Patent: 7,384,653
✉ Email this page to a colleague
Summary for Patent: 7,384,653
| Title: | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
| Abstract: | The present invention provides an oral dosage form comprising a first composition and a second composition. The first composition comprises an effective amount of a therapeutic agent and the second composition comprises an effective amount of an adverse-effect agent. The adverse-effect agent is covered with a coating that is substantially insoluble in the gastrointestinal tract. In one embodiment, the adverse-effect agent is coated with an outer base-soluble layer and an inner acid-soluble layer. The therapeutic agent can be uncoated or can be coated with a coating having an outer acid-soluble layer and an inner base-soluble layer. The dosage form discourages administration of the therapeutic agent by other than oral administration. |
| Inventor(s): | Wright, IV; Curtis (Norwalk, CT), Carpanzano; Anthony E. (Sherman, CT) |
| Assignee: | Purdue Pharma L.P. (Stamford, CT) |
| Application Number: | 10/948,575 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,384,653
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Jubilant Hollisterstier Llc | N/A | positive skin test control-histamine | Injection | 103891 | 03/13/1924 | ⤷ Try a Trial | 2039-02-26 |
| Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2039-02-26 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
